GlassScriptPhysician profile
Lisa R Hall
NPI 1922033513
$2,573.22
in general payments reported to CMS, 2019-2025
39 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $195 · 2021: $430 · 2022: $427 · 2023: $443 · 2024: $325 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,192.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $371.91 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $361.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $240.30 | 2019-2024 | Trintellix |
| Glaxosmithkline, LLC. | $161.37 | 2019-2025 | Shingrix, Bexsero, Arexvy |
| Abbvie INC. | $154.81 | 2019-2024 | |
| Corium, LLC | $139.50 | 2021-2025 | Azstarys |
| Pfizer INC. | $132.21 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $119.34 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $86.42 | 2020-2024 | Rotateq, Gardasil 9, Vaxelis |
| Biohaven Pharmaceutical Holding Company LTD. | $71.35 | 2022 | |
| Amgen INC. | $61.57 | 2020-2025 | Repatha, Otezla, Repatha |
| Midmark Corporation | $58.99 | 2019 | |
| Exact Sciences Corporation | $58.78 | 2023-2024 | Cologuard Collection Kit |
| Collegium Pharmaceutical, INC. | $48.06 | 2025 | Jornay Pm |
| Biohaven Pharmaceuticals, INC. | $46.56 | 2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.